NCT06144619View on ClinicalTrials.gov

Non-Invasive Biomarkers in Prostate Cancer Disease Management

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 21, 2023

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Prostate Cancer
Interventions
GENETIC

Genomic and Histological Evaluation

Participants will obtain genomic and histological evaluation on their biopsied samples. (Follows SOC)

Trial Locations (1)

33612

RECRUITING

Moffitt Cancer Center, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER